SEC 13D/G

$MBX SEC Filing Update (24-JUN-2026) | ThinkSabio - Stocks Simplified

$MBX$48.40▲ 58.58% YTDHealthcareJun 24, 2026 · ThinkSabio Blog

SEC Filing Update: #MBX : $48.40

Sector: Healthcare | YTD: 🔼+ 58.58% The SEC disclosed Today (24-JUN-2026) that Paradigm Biocapital Advisors LP has Newly bought 2,493,015 #MBX shares Ownership: 5.2% * Estimated Investment Value: $101.29M https://www.thinksabio.com/reports/isr/MBX Institutional ownership in #MBX has been steadily rising over the past 8 quarters in Shares: Q2 2024: 0.00 Q3 2024: 30.28M Q4 2024: 32.94M Q1 2025: 35.67M Q2 2025: 36.84M Q3 2025: 47.79M Q4 2025: 48.43M Q1 2026: 52.54M The quarterly average prices of #MBX: Q3 2025: $13.38 Q4 2025: $24.14 Q1 2026: $34.01

Share this post

More filings for $MBX

MBX ▼ -0.1% - MBX Biosciences, Inc.Sep 23, 2026 MBX ▼ -0.5% - MBX Biosciences, Inc.Sep 9, 2026 MBX ▼ -0.8% - MBX Biosciences, Inc.Sep 9, 2026 MBX - MBX Biosciences, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026 MBX - MBX Biosciences, Inc. - SEC Filing Update (10-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 10, 2026 MBX - MBX Biosciences, Inc. - SEC Filing Update (10-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 10, 2026

View full $MBX filing history →

💬 Comments

Loading comments…